Crossmark

T2-weighted MRI radiomics in high-grade intramedullary osteosarcoma: predictive accuracy in assessing histologic response to chemotherapy, overall survival, and disease-free survival

Crossref DOI link: https://doi.org/10.1007/s00256-022-04098-2

Published Online: 2022-07-01

Published Print: 2023-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

White, Lawrence M.

Atinga, Angela

Naraghi, Ali M.

Lajkosz, Katherine

Wunder, Jay S.

Ferguson, Peter

Tsoi, Kim

Griffin, Anthony

Haider, Masoom
License Information

Text and Data Mining valid from 2022-07-01

Version of Record valid from 2022-07-01
More Information

Article History

Received: 2 May 2022

Revised: 16 June 2022

Accepted: 17 June 2022

First Online: 1 July 2022

Declarations

:

: Ethics approval was granted by our institutional review board for this study.

: None to declare from all authors. The authors attest that this manuscript submission does not include any material copyrighted by other sources.

Document is current

Any future updates will be listed below